Posted: January 26th, 2018

Bladder cancer : The 2 Amazing Solutions Offered by cycle–nonspecific alkylating agent thiotepa (Thioplex)

A male client is receiving the cell cycle–nonspecific alkylating agent thiotepa (Thioplex), 60 mg weekly for 4 weeks by bladder instillation as part of a chemotherapeutic regimen to treat bladder cancer.

The client asks the nurse how the drug works. How does thiotepa exert its therapeutic effects?

A. It interferes with deoxyribonucleic acid (DNA) replication only.
B. It interferes with ribonucleic acid (RNA) transcription only.
C. It interferes with DNA replication and RNA transcription.
D. It destroys the cell membrane, causing lysis.

bladder cancer
Bladder cancer medical concept as a urinary anatomical organ symbol with microscopic cancerous malignant cells spreading in the human body as a healthcare 3D illustration.

Expert paper writers are just a few clicks away

Place an order in 3 easy steps. Takes less than 5 mins.

Calculate the price of your order

You will get a personal manager and a discount.
We'll send you the first draft for approval by at
Total price:
Live Chat+1-631-333-0101EmailWhatsApp